IL137809A0 - Pneumococcal and meningococcal vaccines formulated with interleukin-12 - Google Patents

Pneumococcal and meningococcal vaccines formulated with interleukin-12

Info

Publication number
IL137809A0
IL137809A0 IL13780999A IL13780999A IL137809A0 IL 137809 A0 IL137809 A0 IL 137809A0 IL 13780999 A IL13780999 A IL 13780999A IL 13780999 A IL13780999 A IL 13780999A IL 137809 A0 IL137809 A0 IL 137809A0
Authority
IL
Israel
Prior art keywords
pneumococcal
interleukin
vaccines formulated
meningococcal vaccines
meningococcal
Prior art date
Application number
IL13780999A
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL137809A0 publication Critical patent/IL137809A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55538—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
IL13780999A 1998-02-12 1999-02-10 Pneumococcal and meningococcal vaccines formulated with interleukin-12 IL137809A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7452898P 1998-02-12 1998-02-12
PCT/US1999/002847 WO1999040936A2 (en) 1998-02-12 1999-02-10 Pneumococcal and meningococcal vaccines formulated with interleukin-12

Publications (1)

Publication Number Publication Date
IL137809A0 true IL137809A0 (en) 2001-10-31

Family

ID=22120049

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13780999A IL137809A0 (en) 1998-02-12 1999-02-10 Pneumococcal and meningococcal vaccines formulated with interleukin-12
IL137809A IL137809A (en) 1998-02-12 2000-08-10 Pneumococcal and meningococcal vaccines formulated with interleukin-12

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL137809A IL137809A (en) 1998-02-12 2000-08-10 Pneumococcal and meningococcal vaccines formulated with interleukin-12

Country Status (9)

Country Link
EP (1) EP1053015A2 (en)
JP (3) JP2002502882A (en)
KR (1) KR100585408B1 (en)
CN (1) CN1200730C (en)
AU (1) AU759391B2 (en)
BR (1) BR9907884A (en)
CA (1) CA2320223A1 (en)
IL (2) IL137809A0 (en)
WO (1) WO1999040936A2 (en)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9907884A (en) * 1998-02-12 2000-10-24 American Cyanamid Co Vaccine composition, processes for generating an immune response in a pneumococcal antigen, for increasing ifn-gamma response in a pneumococcal vaccine, and for generating complementary attachment antibodies for a protective response to a pathogen, immunogenic composition, and, process for generating an immune response in a meningococcal antigen
US6908757B1 (en) 1998-03-26 2005-06-21 The Procter & Gamble Company Serine protease variants having amino acid deletions and substitutions
CA2379712A1 (en) 1999-07-22 2001-02-01 The Procter & Gamble Company Subtilisin protease variants having amino acid deletions and substitutions in defined epitope regions
KR20020021398A (en) 1999-07-22 2002-03-20 데이비드 엠 모이어 Subtilisin protease variants having amino acid substitutions in defined epitope regions
US6946128B1 (en) 1999-07-22 2005-09-20 The Procter & Gamble Company Protease conjugates having sterically protected epitope regions
WO2001007484A2 (en) 1999-07-22 2001-02-01 The Procter & Gamble Company Protease conjugates having sterically protected clip sites
SI2353608T1 (en) 2002-10-11 2020-12-31 Glaxosmithkline Biologicals Sa Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages
US10272147B2 (en) 2003-01-30 2019-04-30 Glaxosmithkline Biologicals S.A. Injectable vaccines against multiple meningococcal serogroups
US8765135B2 (en) 2003-10-02 2014-07-01 Novartis Ag Liquid vaccines for multiple meningococcal serogroups
GB0500787D0 (en) 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
EP1740217B1 (en) 2004-04-30 2011-06-15 Novartis Vaccines and Diagnostics S.r.l. Meningococcal conjugate vaccination
GB0409745D0 (en) 2004-04-30 2004-06-09 Chiron Srl Compositions including unconjugated carrier proteins
GB0410866D0 (en) 2004-05-14 2004-06-16 Chiron Srl Haemophilius influenzae
GB0424092D0 (en) 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
GB0502095D0 (en) 2005-02-01 2005-03-09 Chiron Srl Conjugation of streptococcal capsular saccharides
NZ597685A (en) 2005-02-18 2013-12-20 Novartis Vaccines & Diagnostic Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
EP1858919B1 (en) 2005-02-18 2012-04-04 Novartis Vaccines and Diagnostics, Inc. Immunogens from uropathogenic escherichia coli
EP2425853A1 (en) * 2005-04-08 2012-03-07 Wyeth LLC Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
US20090074712A1 (en) * 2005-05-19 2009-03-19 Compton Methods for Treatment and Prevention of Infection
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
WO2008020330A2 (en) 2006-08-16 2008-02-21 Novartis Ag Immunogens from uropathogenic escherichia coli
GB0713880D0 (en) 2007-07-17 2007-08-29 Novartis Ag Conjugate purification
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
GB0818453D0 (en) 2008-10-08 2008-11-12 Novartis Ag Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
AU2009215364B2 (en) 2008-02-21 2014-09-18 Glaxosmithkline Biologicals S.A. Meningococcal fHBP polypeptides
JP2012519482A (en) 2009-03-06 2012-08-30 ノバルティス アーゲー Chlamydia antigen
SI2510947T1 (en) 2009-04-14 2016-05-31 Glaxosmithkline Biologicals S.A. Compositions for immunising against Staphylococcus aureus
SG177533A1 (en) 2009-07-07 2012-02-28 Novartis Ag Conserved escherichia coli immunogens
CN102770443A (en) 2009-07-16 2012-11-07 诺华有限公司 Detoxified escherichia coli immunogens
CN104650241A (en) 2009-08-27 2015-05-27 诺华股份有限公司 Hybrid polypeptides including meningococcal fHBP sequences
JP2013504556A (en) 2009-09-10 2013-02-07 ノバルティス アーゲー Combination vaccine for respiratory tract disease
GB0917002D0 (en) 2009-09-28 2009-11-11 Novartis Vaccines Inst For Global Health Srl Improved shigella blebs
GB0917003D0 (en) 2009-09-28 2009-11-11 Novartis Vaccines Inst For Global Health Srl Purification of bacterial vesicles
CN102596254B (en) 2009-09-30 2016-10-19 诺华股份有限公司 Staphylococcus aureus 5 type and the coupling of CP8
US20130022639A1 (en) 2009-09-30 2013-01-24 Novartis Ag Expression of meningococcal fhbp polypeptides
GB0918392D0 (en) 2009-10-20 2009-12-02 Novartis Ag Diagnostic and therapeutic methods
WO2011051893A1 (en) 2009-10-27 2011-05-05 Novartis Ag Modified meningococcal fhbp polypeptides
GB0919690D0 (en) 2009-11-10 2009-12-23 Guy S And St Thomas S Nhs Foun compositions for immunising against staphylococcus aureus
JP5781542B2 (en) 2009-12-30 2015-09-24 ノバルティス アーゲー E. polysaccharide immunogen conjugated to an E. coli carrier protein
GB201003333D0 (en) 2010-02-26 2010-04-14 Novartis Ag Immunogenic proteins and compositions
GB201005625D0 (en) 2010-04-01 2010-05-19 Novartis Ag Immunogenic proteins and compositions
EP2556151A1 (en) 2010-04-07 2013-02-13 Novartis AG Method for generating a parvovirus b19 virus-like particle
GB201009861D0 (en) 2010-06-11 2010-07-21 Novartis Ag OMV vaccines
US20130171185A1 (en) 2010-07-06 2013-07-04 Ethan Settembre Norovirus derived immunogenic compositions and methods
GB201101665D0 (en) 2011-01-31 2011-03-16 Novartis Ag Immunogenic compositions
GB201017519D0 (en) 2010-10-15 2010-12-01 Novartis Vaccines Inst For Global Health S R L Vaccines
WO2012072769A1 (en) 2010-12-01 2012-06-07 Novartis Ag Pneumococcal rrgb epitopes and clade combinations
US20130315959A1 (en) 2010-12-24 2013-11-28 Novartis Ag Compounds
EP2736921B1 (en) 2011-07-25 2018-06-27 GlaxoSmithKline Biologicals SA Compositions and methods for assessing functional immunogenicity of parvovirus vaccines
GB201114923D0 (en) 2011-08-30 2011-10-12 Novartis Ag Immunogenic proteins and compositions
US9511130B2 (en) 2011-09-14 2016-12-06 Glaxosmithkline Biologicals Sa Escherichia coli vaccine combination
ES2732708T3 (en) 2011-09-14 2019-11-25 Glaxosmithkline Biologicals Sa Manufacturing procedures of saccharide-protein glucoconjugates
JP6084631B2 (en) 2011-12-08 2017-02-22 ノバルティス アーゲー Clostridium difficile toxin-based vaccine
WO2013108272A2 (en) 2012-01-20 2013-07-25 International Centre For Genetic Engineering And Biotechnology Blood stage malaria vaccine
WO2013124473A1 (en) 2012-02-24 2013-08-29 Novartis Ag Pilus proteins and compositions
US10279026B2 (en) 2012-04-26 2019-05-07 Glaxosmithkline Biologicals Sa Antigens and antigen combinations
MX2014012444A (en) 2012-04-26 2015-01-14 Novartis Ag Antigens and antigen combinations.
AU2013265336A1 (en) 2012-05-22 2014-12-04 Novartis Ag Meningococcus serogroup X conjugate
RU2662970C2 (en) 2012-09-18 2018-07-31 Новартис Аг Outer membrane vesicles
KR20150060986A (en) 2012-10-02 2015-06-03 글락소스미스클라인 바이오로지칼즈 에스.에이. Nonlinear saccharide conjugate
US9855325B2 (en) 2012-10-03 2018-01-02 Glaxosmithkline Biologicals Sa Immunogenic composition
EP2925355B1 (en) 2012-11-30 2017-11-15 GlaxoSmithKline Biologicals S.A. Pseudomonas antigens and antigen combinations
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
CN114544913B (en) * 2022-02-23 2024-04-09 沈阳建筑大学 Soil investigation encryption sampling distribution optimization method

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5153312A (en) * 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
US5571515A (en) * 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
JPH10502366A (en) * 1994-07-01 1998-03-03 リカン・リミテッド Helicobacter pylori antigen protein preparation and immunoassay
WO1996011019A1 (en) * 1994-10-05 1996-04-18 Vanderbilt University Interleukin-12 as an adjuvant for paramyxoviridae vaccines
GB9422990D0 (en) * 1994-11-15 1995-01-04 Cortecs Ltd Immunogenic compositions
US5866134A (en) * 1995-03-24 1999-02-02 Schering Corporation Method for enhancing the antibody response to specific antigens with Interleukin-10
AU5507098A (en) * 1995-12-19 1998-03-19 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Enhancement of dna immunization through the use of cytokines
JP3737519B2 (en) * 1996-05-31 2006-01-18 ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー IL-12 as an adjuvant for Bordetella pertussis vaccine
US6438586B1 (en) * 1996-09-30 2002-08-20 Emc Corporation File transfer utility which employs an intermediate data storage system
BR9907884A (en) * 1998-02-12 2000-10-24 American Cyanamid Co Vaccine composition, processes for generating an immune response in a pneumococcal antigen, for increasing ifn-gamma response in a pneumococcal vaccine, and for generating complementary attachment antibodies for a protective response to a pathogen, immunogenic composition, and, process for generating an immune response in a meningococcal antigen
US6303114B1 (en) * 1998-03-05 2001-10-16 The Medical College Of Ohio IL-12 enhancement of immune responses to T-independent antigens

Also Published As

Publication number Publication date
AU759391B2 (en) 2003-04-10
JP2010006827A (en) 2010-01-14
IL137809A (en) 2007-12-03
WO1999040936A3 (en) 1999-10-28
KR100585408B1 (en) 2006-06-01
EP1053015A2 (en) 2000-11-22
JP2010265279A (en) 2010-11-25
KR20010040898A (en) 2001-05-15
AU2596599A (en) 1999-08-30
BR9907884A (en) 2000-10-24
CA2320223A1 (en) 1999-08-19
CN1200730C (en) 2005-05-11
WO1999040936A2 (en) 1999-08-19
CN1292706A (en) 2001-04-25
JP2002502882A (en) 2002-01-29

Similar Documents

Publication Publication Date Title
IL137809A0 (en) Pneumococcal and meningococcal vaccines formulated with interleukin-12
HUS1300050I1 (en) Adjuvant systems and vaccines
PL332633A1 (en) Vaccines
AU5565599A (en) Chemically modified saponins and the use thereof as adjuvants
HU9903361D0 (en) Filter-device with collecting-vessel and with heating-device
AU9272401A (en) Cripto mutant and uses thereof
EP0958373A4 (en) Vaccines
HUP0102496A3 (en) Haemophilus parasuis vaccine and diagnostic
AU134012S (en) Pillow
GB9806666D0 (en) Antigen preparation and use
IL129530A0 (en) Acellular pertussis vaccine with diphtheria and tetanus-toxoids
GB9410922D0 (en) Vaccines
EP0673999A3 (en) Trehalose phosphorylase and preparation thereof.
GB9822714D0 (en) Vaccines
GB9611673D0 (en) Meningococcal vaccine
CZ20011896A3 (en) Immunogenic preparation and antibody
ZA955128B (en) Novel amido-quinoxalinediones the preparation and use thereof
GB9609252D0 (en) Vaccines
GB9406708D0 (en) Vaccines
IL148863A0 (en) Components for use in producing paclitaxal and methods for the preparation thereof
GB9416667D0 (en) Vaccines and diagnostics
TW309947U (en) Pillow
AU128231S (en) Pillow
AU127497S (en) Cervical pillow
GB9614182D0 (en) Vaccines

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed